Basic Science & Pathogenesis Providing Quality HIV Care HIV Treatment Strategies FDA-Approved HIV Medications Adverse Events & Comorbidities Care & Services Outside the U.S.

Mental Health Discrimination & Law Meeting the Costs of Care Case Management & Social Work Policy & Advocacy Care & Services Outside the U.S.

HIV Transmission & Testing

Epidemiology Education & Risk Management Prevention Methods HIV Testing

Research & Conferences

This Week in HIV Research IAS 2019: What to Expect in HIV Science CROI 2019 All Conference Coverage Newsroom

All Categories Visit TheBody (Our HIV Community Resource)

SUBSCRIBE TO OUR NEWSLETTER

About Contact Write For Us

https://www.thebodypro.com/author/canadian-aids-treatment-information-exchange

Canadian AIDS Treatment Information Exchange

About CATIE

CATIE's Vision
CATIE envisions a future free of HIV and hepatitis C.

CATIE's Mission
CATIE is Canada's source for accessible, evidence-based information about HIV and hepatitis C prevention, testing, care, treatment and support. CATIE strengthens the national response to HIV and hepatitis C by fostering collaboration and capacity among people living with HIV and/or hepatitis C and other affected populations, frontline service providers and researchers to reduce transmission and improve health and well-being.

Our Services
CATIE is Canada's source for up-to-date, unbiased information about HIV and hepatitis C. We connect people living with HIV or hepatitis C, at-risk communities, healthcare providers and community organizations with the knowledge, resources and expertise to reduce transmission and improve quality of life.

Connect With the Tools You Need
The latest news about HIV and hepatitis C treatment and prevention in clear language

Accurate online information
Research updates
Confidential inquiry line

Resources developed in partnership with organizations across Canada

Free publications
Program tools
Case studies

Events for service providers to share approaches and lessons learned

CATIE Forum
Regional conferences
Learning Institutes

Educational opportunities in person and online

Webinars
Workshops
Training courses

Order a CATIE Brochure
This bilingual brochure provides a brief overview of CATIE's programs and services. Order a copy from the CATIE Ordering Centre.

CATIE's History

Read more about CATIE's history and milestones.

How to Reach CATIE

CATIE (Canadian AIDS Treatment Information Exchange)
555 Richmond Street West, Suite 505
Box 1104
Toronto, Ontario M5V 3B1 Canada

Phone: 416.203.7122 or 1.800.263.1638
Fax: 416.203.8284
E-mail: info@catie.ca
Web: www.catie.ca
Facebook: www.facebook.com/CATIEInfo/
Twitter: https://twitter.com/CATIEinfo

Conditions Covered: HIV Epidemiology, Adverse Events, Comorbidities, and HIV, HIV and Mental Health Care, Tenofovir Disoproxil Fumarate (Viread), Switching or Stopping HIV Treatment, Managing People Newly Diagnosed With HIV, HIV Care Continuum, Providing Quality HIV Care, U=U (Undetectable Equals Untransmittable, i.e. HIV Treatment as Prevention), HIV Testing, Managing Primary/Acute HIV Infection, HIV Prevention Methods, Lopinavir/Ritonavir (Kaletra), Raltegravir (Isentress), HIV Treatment Strategies, PrEP (HIV Pre-Exposure Prophylaxis), HIV Education and Risk Management, HIV, Discrimination, and Law, HIV Treatments in Development, HIV Care and Services Outside the US, HIV Basic Science and Pathogenesis, Cobicistat/Emtricitabine/Elvitegravir/Tenofovir Alafenamide (Genvoya, E/C/F/TAF), Pregnancy, Childbirth, and HIV, Managing Long-Term HIV Survivors, PEP (HIV Post-Exposure Prophylaxis), Rilpivirine (Edurant), Efavirenz (Sustiva, Stocrin), Dolutegravir (Tivicay), FDA-Approved HIV Medications, Bictegravir/Emtricitabine/Tenofovir Alafenamide (Biktarvy, B/F/TAF), Darunavir (Prezista), First-Line HIV Treatment, Meeting the Costs of HIV Care, Ritonavir (Norvir), Emtricitabine/Tenofovir Alafenamide (Descovy), Maraviroc (Selzentry, Celsentri), Abacavir (Ziagen), Etravirine (Intelence), HIV Case Management and Social Work, Managing HIV Drug Resistance, Nevirapine (Viramune), Didanosine (ddI, Videx), Atazanavir (Reyataz), Enfuvirtide (T-20, Fuzeon), Cobicistat/Elvitegravir/Emtricitabine/Tenofovir Disoproxil Fumarate (Stribild), Emtricitabine/Tenofovir Disoproxil Fumarate (Truvada), Cobicistat (Tybost), Pediatric HIV Care, Saquinavir (Invirase),

Latest by Canadian AIDS Treatment Information Exchange

Hepatitis C

Overdoses and Smoking Are Taking the Lives of People With HIV Who Have Been Cured of Hepatitis C

"Providing HCV treatment alone while neglecting to concurrently address the social determinants of health will do little to improve the health outcomes of the majority of individuals with chronic HCV," the study authors wrote.

By Sean R. Hosein for Canadian AIDS Treatment Information Exchange

Neurocognitive

Large French Study Examines Neuropsychiatric Side Effects With Integrase Inhibitors

This will likely become the landmark study about the overall rate of neuropsychiatric side effects with this class of medicines over the next several years.

By Sean R. Hosein for Canadian AIDS Treatment Information Exchange

Men Who Have Sex With Men

Gay Men, Substance Use, and Harm Reduction: It's Time to Act

"Placing more attention on meeting the sexual health and holistic wellness needs of gay men affected by sexualized substance use is critical," writes the associate director of Ontario's Gay Men's Sexual Health Alliance.

By Dane Griffiths for Canadian AIDS Treatment Information Exchange

De-Simplifying Single-Tablet Regimens for HIV Treatment

A Canadian study of this cost-saving approach found high acceptance of de-simplification among people already on a single-tablet regimen, and even higher rates among people who were just initiating single-tablet treatment.

By Sean R. Hosein for Canadian AIDS Treatment Information Exchange